nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2D6—Alzheimer's disease	0.277	1	CbGaD
Arformoterol—CYP2A6—Memantine—Alzheimer's disease	0.165	0.349	CbGbCtD
Arformoterol—CYP2D6—Rivastigmine—Alzheimer's disease	0.0749	0.159	CbGbCtD
Arformoterol—CYP2C19—Memantine—Alzheimer's disease	0.0683	0.145	CbGbCtD
Arformoterol—CYP2C9—Donepezil—Alzheimer's disease	0.0655	0.139	CbGbCtD
Arformoterol—CYP2D6—Donepezil—Alzheimer's disease	0.0599	0.127	CbGbCtD
Arformoterol—CYP2D6—Galantamine—Alzheimer's disease	0.0386	0.0817	CbGbCtD
Arformoterol—Asthma—Memantine—Alzheimer's disease	0.000382	0.00177	CcSEcCtD
Arformoterol—Influenza—Memantine—Alzheimer's disease	0.000382	0.00177	CcSEcCtD
Arformoterol—Mental disorder—Galantamine—Alzheimer's disease	0.000381	0.00177	CcSEcCtD
Arformoterol—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00038	0.00176	CcSEcCtD
Arformoterol—Malnutrition—Galantamine—Alzheimer's disease	0.000379	0.00176	CcSEcCtD
Arformoterol—Bronchospasm—Memantine—Alzheimer's disease	0.000376	0.00175	CcSEcCtD
Arformoterol—Angina pectoris—Memantine—Alzheimer's disease	0.000373	0.00173	CcSEcCtD
Arformoterol—Tension—Galantamine—Alzheimer's disease	0.000372	0.00172	CcSEcCtD
Arformoterol—Dysgeusia—Galantamine—Alzheimer's disease	0.000371	0.00172	CcSEcCtD
Arformoterol—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00037	0.00172	CcSEcCtD
Arformoterol—Myocardial infarction—Donepezil—Alzheimer's disease	0.000368	0.00171	CcSEcCtD
Arformoterol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000368	0.00171	CcSEcCtD
Arformoterol—Nervousness—Galantamine—Alzheimer's disease	0.000368	0.00171	CcSEcCtD
Arformoterol—Bronchitis—Memantine—Alzheimer's disease	0.000368	0.00171	CcSEcCtD
Arformoterol—Back pain—Galantamine—Alzheimer's disease	0.000366	0.0017	CcSEcCtD
Arformoterol—Conjunctivitis—Donepezil—Alzheimer's disease	0.000365	0.00169	CcSEcCtD
Arformoterol—Urinary tract infection—Donepezil—Alzheimer's disease	0.000365	0.00169	CcSEcCtD
Arformoterol—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000364	0.00169	CcSEcCtD
Arformoterol—Muscle spasms—Galantamine—Alzheimer's disease	0.000364	0.00169	CcSEcCtD
Arformoterol—Bronchitis—Rivastigmine—Alzheimer's disease	0.00036	0.00167	CcSEcCtD
Arformoterol—Haematuria—Donepezil—Alzheimer's disease	0.000358	0.00166	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000355	0.00165	CcSEcCtD
Arformoterol—Tremor—Galantamine—Alzheimer's disease	0.000355	0.00165	CcSEcCtD
Arformoterol—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000351	0.00163	CcSEcCtD
Arformoterol—Agitation—Galantamine—Alzheimer's disease	0.000348	0.00161	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000348	0.00161	CcSEcCtD
Arformoterol—Hyperglycaemia—Memantine—Alzheimer's disease	0.000345	0.0016	CcSEcCtD
Arformoterol—Malaise—Galantamine—Alzheimer's disease	0.000341	0.00158	CcSEcCtD
Arformoterol—Rhinitis—Donepezil—Alzheimer's disease	0.000338	0.00157	CcSEcCtD
Arformoterol—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000337	0.00157	CcSEcCtD
Arformoterol—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000336	0.00156	CcSEcCtD
Arformoterol—Palpitations—Galantamine—Alzheimer's disease	0.000335	0.00155	CcSEcCtD
Arformoterol—Pharyngitis—Donepezil—Alzheimer's disease	0.000335	0.00155	CcSEcCtD
Arformoterol—Myocardial infarction—Memantine—Alzheimer's disease	0.000334	0.00155	CcSEcCtD
Arformoterol—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000333	0.00154	CcSEcCtD
Arformoterol—Oedema peripheral—Donepezil—Alzheimer's disease	0.000332	0.00154	CcSEcCtD
Arformoterol—Urinary tract infection—Memantine—Alzheimer's disease	0.000331	0.00154	CcSEcCtD
Arformoterol—Conjunctivitis—Memantine—Alzheimer's disease	0.000331	0.00154	CcSEcCtD
Arformoterol—Urethral disorder—Donepezil—Alzheimer's disease	0.00033	0.00153	CcSEcCtD
Arformoterol—Cough—Galantamine—Alzheimer's disease	0.00033	0.00153	CcSEcCtD
Arformoterol—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000329	0.00153	CcSEcCtD
Arformoterol—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000327	0.00152	CcSEcCtD
Arformoterol—Hypertension—Galantamine—Alzheimer's disease	0.000327	0.00152	CcSEcCtD
Arformoterol—Haematuria—Memantine—Alzheimer's disease	0.000325	0.00151	CcSEcCtD
Arformoterol—Visual impairment—Donepezil—Alzheimer's disease	0.000325	0.00151	CcSEcCtD
Arformoterol—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000324	0.0015	CcSEcCtD
Arformoterol—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000324	0.0015	CcSEcCtD
Arformoterol—Chest pain—Galantamine—Alzheimer's disease	0.000322	0.0015	CcSEcCtD
Arformoterol—Arthralgia—Galantamine—Alzheimer's disease	0.000322	0.0015	CcSEcCtD
Arformoterol—Myalgia—Galantamine—Alzheimer's disease	0.000322	0.0015	CcSEcCtD
Arformoterol—Anxiety—Galantamine—Alzheimer's disease	0.000321	0.00149	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00032	0.00149	CcSEcCtD
Arformoterol—Sinusitis—Memantine—Alzheimer's disease	0.00032	0.00148	CcSEcCtD
Arformoterol—Discomfort—Galantamine—Alzheimer's disease	0.000319	0.00148	CcSEcCtD
Arformoterol—Haematuria—Rivastigmine—Alzheimer's disease	0.000318	0.00148	CcSEcCtD
Arformoterol—Dry mouth—Galantamine—Alzheimer's disease	0.000315	0.00146	CcSEcCtD
Arformoterol—Sinusitis—Rivastigmine—Alzheimer's disease	0.000313	0.00145	CcSEcCtD
Arformoterol—Rhinitis—Memantine—Alzheimer's disease	0.000307	0.00142	CcSEcCtD
Arformoterol—Pharyngitis—Memantine—Alzheimer's disease	0.000304	0.00141	CcSEcCtD
Arformoterol—Nervous system disorder—Galantamine—Alzheimer's disease	0.000303	0.00141	CcSEcCtD
Arformoterol—Urinary tract disorder—Memantine—Alzheimer's disease	0.000302	0.0014	CcSEcCtD
Arformoterol—Tachycardia—Galantamine—Alzheimer's disease	0.000302	0.0014	CcSEcCtD
Arformoterol—Oedema peripheral—Memantine—Alzheimer's disease	0.000302	0.0014	CcSEcCtD
Arformoterol—Arrhythmia—Donepezil—Alzheimer's disease	0.000301	0.0014	CcSEcCtD
Arformoterol—Connective tissue disorder—Memantine—Alzheimer's disease	0.000301	0.0014	CcSEcCtD
Arformoterol—Rhinitis—Rivastigmine—Alzheimer's disease	0.0003	0.00139	CcSEcCtD
Arformoterol—Skin disorder—Galantamine—Alzheimer's disease	0.0003	0.00139	CcSEcCtD
Arformoterol—Urethral disorder—Memantine—Alzheimer's disease	0.0003	0.00139	CcSEcCtD
Arformoterol—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000297	0.00138	CcSEcCtD
Arformoterol—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000296	0.00137	CcSEcCtD
Arformoterol—Mental disorder—Donepezil—Alzheimer's disease	0.000295	0.00137	CcSEcCtD
Arformoterol—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000295	0.00137	CcSEcCtD
Arformoterol—Visual impairment—Memantine—Alzheimer's disease	0.000295	0.00137	CcSEcCtD
Arformoterol—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000294	0.00137	CcSEcCtD
Arformoterol—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000294	0.00136	CcSEcCtD
Arformoterol—Malnutrition—Donepezil—Alzheimer's disease	0.000293	0.00136	CcSEcCtD
Arformoterol—Hypotension—Galantamine—Alzheimer's disease	0.000289	0.00134	CcSEcCtD
Arformoterol—Visual impairment—Rivastigmine—Alzheimer's disease	0.000289	0.00134	CcSEcCtD
Arformoterol—Tension—Donepezil—Alzheimer's disease	0.000288	0.00134	CcSEcCtD
Arformoterol—Dysgeusia—Donepezil—Alzheimer's disease	0.000287	0.00133	CcSEcCtD
Arformoterol—Nervousness—Donepezil—Alzheimer's disease	0.000285	0.00132	CcSEcCtD
Arformoterol—Cardiac disorder—Memantine—Alzheimer's disease	0.000284	0.00132	CcSEcCtD
Arformoterol—Back pain—Donepezil—Alzheimer's disease	0.000284	0.00132	CcSEcCtD
Arformoterol—Muscle spasms—Donepezil—Alzheimer's disease	0.000282	0.00131	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000282	0.00131	CcSEcCtD
Arformoterol—Insomnia—Galantamine—Alzheimer's disease	0.00028	0.0013	CcSEcCtD
Arformoterol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000278	0.00129	CcSEcCtD
Arformoterol—Immune system disorder—Memantine—Alzheimer's disease	0.000276	0.00128	CcSEcCtD
Arformoterol—Mediastinal disorder—Memantine—Alzheimer's disease	0.000276	0.00128	CcSEcCtD
Arformoterol—Tremor—Donepezil—Alzheimer's disease	0.000275	0.00128	CcSEcCtD
Arformoterol—Somnolence—Galantamine—Alzheimer's disease	0.000275	0.00127	CcSEcCtD
Arformoterol—Arrhythmia—Memantine—Alzheimer's disease	0.000273	0.00127	CcSEcCtD
Arformoterol—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000272	0.00126	CcSEcCtD
Arformoterol—Dyspepsia—Galantamine—Alzheimer's disease	0.000272	0.00126	CcSEcCtD
Arformoterol—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00027	0.00125	CcSEcCtD
Arformoterol—Agitation—Donepezil—Alzheimer's disease	0.00027	0.00125	CcSEcCtD
Arformoterol—Mental disorder—Memantine—Alzheimer's disease	0.000268	0.00124	CcSEcCtD
Arformoterol—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000267	0.00124	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000267	0.00124	CcSEcCtD
Arformoterol—Malnutrition—Memantine—Alzheimer's disease	0.000266	0.00124	CcSEcCtD
Arformoterol—Fatigue—Galantamine—Alzheimer's disease	0.000266	0.00124	CcSEcCtD
Arformoterol—Malaise—Donepezil—Alzheimer's disease	0.000265	0.00123	CcSEcCtD
Arformoterol—Constipation—Galantamine—Alzheimer's disease	0.000264	0.00123	CcSEcCtD
Arformoterol—Mental disorder—Rivastigmine—Alzheimer's disease	0.000262	0.00122	CcSEcCtD
Arformoterol—Tension—Memantine—Alzheimer's disease	0.000261	0.00121	CcSEcCtD
Arformoterol—Dysgeusia—Memantine—Alzheimer's disease	0.000261	0.00121	CcSEcCtD
Arformoterol—Malnutrition—Rivastigmine—Alzheimer's disease	0.000261	0.00121	CcSEcCtD
Arformoterol—Nervousness—Memantine—Alzheimer's disease	0.000259	0.0012	CcSEcCtD
Arformoterol—Back pain—Memantine—Alzheimer's disease	0.000258	0.0012	CcSEcCtD
Arformoterol—Cough—Donepezil—Alzheimer's disease	0.000256	0.00119	CcSEcCtD
Arformoterol—Tension—Rivastigmine—Alzheimer's disease	0.000256	0.00119	CcSEcCtD
Arformoterol—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000255	0.00118	CcSEcCtD
Arformoterol—Feeling abnormal—Galantamine—Alzheimer's disease	0.000255	0.00118	CcSEcCtD
Arformoterol—Hypertension—Donepezil—Alzheimer's disease	0.000253	0.00118	CcSEcCtD
Arformoterol—Nervousness—Rivastigmine—Alzheimer's disease	0.000253	0.00117	CcSEcCtD
Arformoterol—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000253	0.00117	CcSEcCtD
Arformoterol—Back pain—Rivastigmine—Alzheimer's disease	0.000252	0.00117	CcSEcCtD
Arformoterol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000251	0.00116	CcSEcCtD
Arformoterol—Myalgia—Donepezil—Alzheimer's disease	0.00025	0.00116	CcSEcCtD
Arformoterol—Chest pain—Donepezil—Alzheimer's disease	0.00025	0.00116	CcSEcCtD
Arformoterol—Arthralgia—Donepezil—Alzheimer's disease	0.00025	0.00116	CcSEcCtD
Arformoterol—Tremor—Memantine—Alzheimer's disease	0.00025	0.00116	CcSEcCtD
Arformoterol—Anxiety—Donepezil—Alzheimer's disease	0.000249	0.00116	CcSEcCtD
Arformoterol—Ill-defined disorder—Memantine—Alzheimer's disease	0.000247	0.00115	CcSEcCtD
Arformoterol—Discomfort—Donepezil—Alzheimer's disease	0.000247	0.00115	CcSEcCtD
Arformoterol—Agitation—Memantine—Alzheimer's disease	0.000245	0.00114	CcSEcCtD
Arformoterol—Dry mouth—Donepezil—Alzheimer's disease	0.000244	0.00113	CcSEcCtD
Arformoterol—Abdominal pain—Galantamine—Alzheimer's disease	0.000244	0.00113	CcSEcCtD
Arformoterol—Body temperature increased—Galantamine—Alzheimer's disease	0.000244	0.00113	CcSEcCtD
Arformoterol—Tremor—Rivastigmine—Alzheimer's disease	0.000244	0.00113	CcSEcCtD
Arformoterol—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000242	0.00112	CcSEcCtD
Arformoterol—Malaise—Memantine—Alzheimer's disease	0.00024	0.00112	CcSEcCtD
Arformoterol—Agitation—Rivastigmine—Alzheimer's disease	0.00024	0.00111	CcSEcCtD
Arformoterol—Oedema—Donepezil—Alzheimer's disease	0.00024	0.00111	CcSEcCtD
Arformoterol—Infection—Donepezil—Alzheimer's disease	0.000238	0.0011	CcSEcCtD
Arformoterol—Palpitations—Memantine—Alzheimer's disease	0.000235	0.00109	CcSEcCtD
Arformoterol—Malaise—Rivastigmine—Alzheimer's disease	0.000235	0.00109	CcSEcCtD
Arformoterol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000235	0.00109	CcSEcCtD
Arformoterol—Cough—Memantine—Alzheimer's disease	0.000233	0.00108	CcSEcCtD
Arformoterol—Palpitations—Rivastigmine—Alzheimer's disease	0.00023	0.00107	CcSEcCtD
Arformoterol—Hypertension—Memantine—Alzheimer's disease	0.00023	0.00107	CcSEcCtD
Arformoterol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000228	0.00106	CcSEcCtD
Arformoterol—Cough—Rivastigmine—Alzheimer's disease	0.000227	0.00106	CcSEcCtD
Arformoterol—Myalgia—Memantine—Alzheimer's disease	0.000227	0.00105	CcSEcCtD
Arformoterol—Arthralgia—Memantine—Alzheimer's disease	0.000227	0.00105	CcSEcCtD
Arformoterol—Chest pain—Memantine—Alzheimer's disease	0.000227	0.00105	CcSEcCtD
Arformoterol—Anxiety—Memantine—Alzheimer's disease	0.000226	0.00105	CcSEcCtD
Arformoterol—Hypertension—Rivastigmine—Alzheimer's disease	0.000225	0.00104	CcSEcCtD
Arformoterol—Discomfort—Memantine—Alzheimer's disease	0.000224	0.00104	CcSEcCtD
Arformoterol—Hypotension—Donepezil—Alzheimer's disease	0.000224	0.00104	CcSEcCtD
Arformoterol—Arthralgia—Rivastigmine—Alzheimer's disease	0.000222	0.00103	CcSEcCtD
Arformoterol—Chest pain—Rivastigmine—Alzheimer's disease	0.000222	0.00103	CcSEcCtD
Arformoterol—Myalgia—Rivastigmine—Alzheimer's disease	0.000222	0.00103	CcSEcCtD
Arformoterol—Dry mouth—Memantine—Alzheimer's disease	0.000222	0.00103	CcSEcCtD
Arformoterol—Asthenia—Galantamine—Alzheimer's disease	0.000222	0.00103	CcSEcCtD
Arformoterol—Anxiety—Rivastigmine—Alzheimer's disease	0.000221	0.00103	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00022	0.00102	CcSEcCtD
Arformoterol—Formoterol—CYP2D6—Alzheimer's disease	0.00022	0.578	CrCbGaD
Arformoterol—Discomfort—Rivastigmine—Alzheimer's disease	0.000219	0.00102	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000218	0.00101	CcSEcCtD
Arformoterol—Oedema—Memantine—Alzheimer's disease	0.000217	0.00101	CcSEcCtD
Arformoterol—Dry mouth—Rivastigmine—Alzheimer's disease	0.000217	0.00101	CcSEcCtD
Arformoterol—Insomnia—Donepezil—Alzheimer's disease	0.000217	0.00101	CcSEcCtD
Arformoterol—Infection—Memantine—Alzheimer's disease	0.000216	0.001	CcSEcCtD
Arformoterol—Dyspnoea—Donepezil—Alzheimer's disease	0.000214	0.000991	CcSEcCtD
Arformoterol—Nervous system disorder—Memantine—Alzheimer's disease	0.000213	0.00099	CcSEcCtD
Arformoterol—Somnolence—Donepezil—Alzheimer's disease	0.000213	0.000988	CcSEcCtD
Arformoterol—Oedema—Rivastigmine—Alzheimer's disease	0.000213	0.000987	CcSEcCtD
Arformoterol—Tachycardia—Memantine—Alzheimer's disease	0.000212	0.000985	CcSEcCtD
Arformoterol—Diarrhoea—Galantamine—Alzheimer's disease	0.000211	0.000981	CcSEcCtD
Arformoterol—Infection—Rivastigmine—Alzheimer's disease	0.000211	0.000981	CcSEcCtD
Arformoterol—Skin disorder—Memantine—Alzheimer's disease	0.000211	0.00098	CcSEcCtD
Arformoterol—Dyspepsia—Donepezil—Alzheimer's disease	0.000211	0.000978	CcSEcCtD
Arformoterol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000209	0.000968	CcSEcCtD
Arformoterol—Tachycardia—Rivastigmine—Alzheimer's disease	0.000208	0.000964	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000207	0.00096	CcSEcCtD
Arformoterol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000207	0.000959	CcSEcCtD
Arformoterol—Fatigue—Donepezil—Alzheimer's disease	0.000206	0.000958	CcSEcCtD
Arformoterol—Constipation—Donepezil—Alzheimer's disease	0.000205	0.00095	CcSEcCtD
Arformoterol—Pain—Donepezil—Alzheimer's disease	0.000205	0.00095	CcSEcCtD
Arformoterol—Dizziness—Galantamine—Alzheimer's disease	0.000204	0.000948	CcSEcCtD
Arformoterol—Hypotension—Memantine—Alzheimer's disease	0.000203	0.000943	CcSEcCtD
Arformoterol—Hypotension—Rivastigmine—Alzheimer's disease	0.000199	0.000922	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000198	0.000919	CcSEcCtD
Arformoterol—Feeling abnormal—Donepezil—Alzheimer's disease	0.000197	0.000916	CcSEcCtD
Arformoterol—Insomnia—Memantine—Alzheimer's disease	0.000197	0.000913	CcSEcCtD
Arformoterol—Vomiting—Galantamine—Alzheimer's disease	0.000196	0.000912	CcSEcCtD
Arformoterol—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000196	0.000909	CcSEcCtD
Arformoterol—Rash—Galantamine—Alzheimer's disease	0.000195	0.000904	CcSEcCtD
Arformoterol—Dermatitis—Galantamine—Alzheimer's disease	0.000195	0.000903	CcSEcCtD
Arformoterol—Dyspnoea—Memantine—Alzheimer's disease	0.000194	0.0009	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000194	0.000899	CcSEcCtD
Arformoterol—Headache—Galantamine—Alzheimer's disease	0.000194	0.000898	CcSEcCtD
Arformoterol—Somnolence—Memantine—Alzheimer's disease	0.000193	0.000897	CcSEcCtD
Arformoterol—Insomnia—Rivastigmine—Alzheimer's disease	0.000192	0.000893	CcSEcCtD
Arformoterol—Dyspepsia—Memantine—Alzheimer's disease	0.000191	0.000888	CcSEcCtD
Arformoterol—Urticaria—Donepezil—Alzheimer's disease	0.00019	0.000883	CcSEcCtD
Arformoterol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00019	0.00088	CcSEcCtD
Arformoterol—Abdominal pain—Donepezil—Alzheimer's disease	0.000189	0.000879	CcSEcCtD
Arformoterol—Body temperature increased—Donepezil—Alzheimer's disease	0.000189	0.000879	CcSEcCtD
Arformoterol—Somnolence—Rivastigmine—Alzheimer's disease	0.000189	0.000878	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000188	0.000871	CcSEcCtD
Arformoterol—Fatigue—Memantine—Alzheimer's disease	0.000187	0.00087	CcSEcCtD
Arformoterol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000187	0.000869	CcSEcCtD
Arformoterol—Pain—Memantine—Alzheimer's disease	0.000186	0.000863	CcSEcCtD
Arformoterol—Constipation—Memantine—Alzheimer's disease	0.000186	0.000863	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000184	0.000852	CcSEcCtD
Arformoterol—Nausea—Galantamine—Alzheimer's disease	0.000184	0.000852	CcSEcCtD
Arformoterol—Fatigue—Rivastigmine—Alzheimer's disease	0.000183	0.000851	CcSEcCtD
Arformoterol—Constipation—Rivastigmine—Alzheimer's disease	0.000182	0.000844	CcSEcCtD
Arformoterol—Pain—Rivastigmine—Alzheimer's disease	0.000182	0.000844	CcSEcCtD
Arformoterol—Feeling abnormal—Memantine—Alzheimer's disease	0.000179	0.000832	CcSEcCtD
Arformoterol—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000178	0.000825	CcSEcCtD
Arformoterol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000176	0.000819	CcSEcCtD
Arformoterol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000175	0.000814	CcSEcCtD
Arformoterol—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000174	0.000807	CcSEcCtD
Arformoterol—Urticaria—Memantine—Alzheimer's disease	0.000173	0.000802	CcSEcCtD
Arformoterol—Body temperature increased—Memantine—Alzheimer's disease	0.000172	0.000798	CcSEcCtD
Arformoterol—Abdominal pain—Memantine—Alzheimer's disease	0.000172	0.000798	CcSEcCtD
Arformoterol—Asthenia—Donepezil—Alzheimer's disease	0.000172	0.000797	CcSEcCtD
Arformoterol—Pruritus—Donepezil—Alzheimer's disease	0.000169	0.000786	CcSEcCtD
Arformoterol—Urticaria—Rivastigmine—Alzheimer's disease	0.000169	0.000784	CcSEcCtD
Arformoterol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000168	0.00078	CcSEcCtD
Arformoterol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000168	0.00078	CcSEcCtD
Arformoterol—Diarrhoea—Donepezil—Alzheimer's disease	0.000164	0.00076	CcSEcCtD
Arformoterol—Labetalol—CYP2D6—Alzheimer's disease	0.00016	0.422	CrCbGaD
Arformoterol—Hypersensitivity—Memantine—Alzheimer's disease	0.00016	0.000743	CcSEcCtD
Arformoterol—Dizziness—Donepezil—Alzheimer's disease	0.000158	0.000735	CcSEcCtD
Arformoterol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000157	0.000727	CcSEcCtD
Arformoterol—Asthenia—Memantine—Alzheimer's disease	0.000156	0.000724	CcSEcCtD
Arformoterol—Pruritus—Memantine—Alzheimer's disease	0.000154	0.000714	CcSEcCtD
Arformoterol—Asthenia—Rivastigmine—Alzheimer's disease	0.000153	0.000708	CcSEcCtD
Arformoterol—Vomiting—Donepezil—Alzheimer's disease	0.000152	0.000707	CcSEcCtD
Arformoterol—Rash—Donepezil—Alzheimer's disease	0.000151	0.000701	CcSEcCtD
Arformoterol—Dermatitis—Donepezil—Alzheimer's disease	0.000151	0.0007	CcSEcCtD
Arformoterol—Pruritus—Rivastigmine—Alzheimer's disease	0.000151	0.000698	CcSEcCtD
Arformoterol—Headache—Donepezil—Alzheimer's disease	0.00015	0.000696	CcSEcCtD
Arformoterol—Diarrhoea—Memantine—Alzheimer's disease	0.000149	0.00069	CcSEcCtD
Arformoterol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000146	0.000675	CcSEcCtD
Arformoterol—Dizziness—Memantine—Alzheimer's disease	0.000144	0.000667	CcSEcCtD
Arformoterol—Nausea—Donepezil—Alzheimer's disease	0.000142	0.00066	CcSEcCtD
Arformoterol—Dizziness—Rivastigmine—Alzheimer's disease	0.000141	0.000653	CcSEcCtD
Arformoterol—Vomiting—Memantine—Alzheimer's disease	0.000138	0.000642	CcSEcCtD
Arformoterol—Rash—Memantine—Alzheimer's disease	0.000137	0.000636	CcSEcCtD
Arformoterol—Dermatitis—Memantine—Alzheimer's disease	0.000137	0.000636	CcSEcCtD
Arformoterol—Headache—Memantine—Alzheimer's disease	0.000136	0.000632	CcSEcCtD
Arformoterol—Vomiting—Rivastigmine—Alzheimer's disease	0.000135	0.000628	CcSEcCtD
Arformoterol—Rash—Rivastigmine—Alzheimer's disease	0.000134	0.000622	CcSEcCtD
Arformoterol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000134	0.000622	CcSEcCtD
Arformoterol—Headache—Rivastigmine—Alzheimer's disease	0.000133	0.000618	CcSEcCtD
Arformoterol—Nausea—Memantine—Alzheimer's disease	0.000129	0.000599	CcSEcCtD
Arformoterol—Nausea—Rivastigmine—Alzheimer's disease	0.000126	0.000586	CcSEcCtD
Arformoterol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	1.93e-05	0.000563	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	1.91e-05	0.000557	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.9e-05	0.000555	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	1.89e-05	0.000551	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	1.89e-05	0.00055	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	1.89e-05	0.00055	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PLD3—Alzheimer's disease	1.89e-05	0.00055	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.89e-05	0.00055	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—MAOB—Alzheimer's disease	1.87e-05	0.000545	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.87e-05	0.000544	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	1.85e-05	0.000538	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	1.85e-05	0.000538	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ND1—Alzheimer's disease	1.85e-05	0.000538	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.83e-05	0.000532	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	1.81e-05	0.000527	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.8e-05	0.000526	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GAPDH—Alzheimer's disease	1.8e-05	0.000525	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.77e-05	0.000515	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.76e-05	0.000512	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.74e-05	0.000508	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—A2M—Alzheimer's disease	1.74e-05	0.000507	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.7e-05	0.000495	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.68e-05	0.00049	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	1.66e-05	0.000485	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.65e-05	0.000481	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.65e-05	0.000479	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.64e-05	0.000478	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	1.63e-05	0.000474	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	1.61e-05	0.00047	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.61e-05	0.000468	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	1.58e-05	0.000459	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.55e-05	0.000453	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.52e-05	0.000443	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.52e-05	0.000443	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ACHE—Alzheimer's disease	1.51e-05	0.000441	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.5e-05	0.000438	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—INPP5D—Alzheimer's disease	1.5e-05	0.000436	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.49e-05	0.000434	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.49e-05	0.000434	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	1.48e-05	0.000432	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	1.47e-05	0.00043	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.46e-05	0.000425	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	1.45e-05	0.000423	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	1.44e-05	0.00042	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	1.43e-05	0.000417	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.42e-05	0.000414	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ENO1—Alzheimer's disease	1.42e-05	0.000413	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PTGS1—Alzheimer's disease	1.42e-05	0.000413	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	1.41e-05	0.000411	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	1.4e-05	0.000408	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CYP2D6—Alzheimer's disease	1.39e-05	0.000405	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.38e-05	0.000403	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	1.38e-05	0.000402	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	1.36e-05	0.000395	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.35e-05	0.000394	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.35e-05	0.000393	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	1.33e-05	0.000389	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	1.33e-05	0.000388	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	1.33e-05	0.000387	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.32e-05	0.000385	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—BCHE—Alzheimer's disease	1.32e-05	0.000384	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	1.3e-05	0.00038	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	1.3e-05	0.000379	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.3e-05	0.000378	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.29e-05	0.000377	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	1.29e-05	0.000377	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	1.29e-05	0.000377	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	1.29e-05	0.000377	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	1.29e-05	0.000376	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	1.28e-05	0.000374	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	1.27e-05	0.000369	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	1.27e-05	0.000369	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	1.27e-05	0.000369	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	1.26e-05	0.000367	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	1.26e-05	0.000367	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	1.26e-05	0.000366	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PLCB1—Alzheimer's disease	1.24e-05	0.000362	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	1.23e-05	0.000359	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	1.21e-05	0.000353	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ABCA1—Alzheimer's disease	1.21e-05	0.000351	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	1.19e-05	0.000347	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.19e-05	0.000347	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.19e-05	0.000347	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	1.19e-05	0.000345	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.18e-05	0.000344	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	1.16e-05	0.000339	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.14e-05	0.000332	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	1.11e-05	0.000324	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	1.1e-05	0.000321	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.1e-05	0.00032	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.09e-05	0.000319	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.09e-05	0.000319	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	1.09e-05	0.000316	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.09e-05	0.000316	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	1.08e-05	0.000316	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.08e-05	0.000316	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.08e-05	0.000316	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	1.08e-05	0.000315	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	1.08e-05	0.000314	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.08e-05	0.000313	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	1.06e-05	0.000309	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.06e-05	0.000309	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	1.06e-05	0.000308	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.05e-05	0.000306	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.04e-05	0.000303	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PPARGC1A—Alzheimer's disease	1.04e-05	0.000303	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—HMOX1—Alzheimer's disease	1.03e-05	0.000301	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	1.03e-05	0.000299	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.01e-05	0.000294	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	1e-05	0.000292	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1e-05	0.000292	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.9e-06	0.000288	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.81e-06	0.000286	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	9.77e-06	0.000285	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—A2M—Alzheimer's disease	9.75e-06	0.000284	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—A2M—Alzheimer's disease	9.67e-06	0.000282	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	9.55e-06	0.000278	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—LPL—Alzheimer's disease	9.46e-06	0.000276	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.45e-06	0.000275	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	9.44e-06	0.000275	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	9.24e-06	0.000269	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ACHE—Alzheimer's disease	9.22e-06	0.000269	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	9.12e-06	0.000266	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	9.05e-06	0.000264	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	8.97e-06	0.000261	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	8.86e-06	0.000258	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	8.8e-06	0.000256	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	8.78e-06	0.000256	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ENO1—Alzheimer's disease	8.64e-06	0.000252	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	8.64e-06	0.000252	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.62e-06	0.000251	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	8.61e-06	0.000251	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	8.57e-06	0.00025	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—MTHFR—Alzheimer's disease	8.52e-06	0.000248	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ACHE—Alzheimer's disease	8.48e-06	0.000247	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	8.48e-06	0.000247	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ACHE—Alzheimer's disease	8.41e-06	0.000245	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	8.39e-06	0.000244	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	8.39e-06	0.000244	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	8.34e-06	0.000243	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	8.31e-06	0.000242	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	8.16e-06	0.000238	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	8.16e-06	0.000238	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—BCHE—Alzheimer's disease	8.04e-06	0.000234	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	7.98e-06	0.000233	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CALM1—Alzheimer's disease	7.96e-06	0.000232	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.95e-06	0.000232	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.95e-06	0.000232	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—APOE—Alzheimer's disease	7.93e-06	0.000231	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	7.88e-06	0.00023	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ENO1—Alzheimer's disease	7.88e-06	0.00023	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CAV1—Alzheimer's disease	7.86e-06	0.000229	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	7.73e-06	0.000225	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	7.62e-06	0.000222	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	7.59e-06	0.000221	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	7.59e-06	0.000221	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	7.58e-06	0.000221	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	7.52e-06	0.000219	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	7.45e-06	0.000217	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.44e-06	0.000217	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	7.42e-06	0.000216	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	7.42e-06	0.000216	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.39e-06	0.000215	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	7.36e-06	0.000214	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	7.35e-06	0.000214	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—BCHE—Alzheimer's disease	7.33e-06	0.000213	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	7.25e-06	0.000211	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	7.16e-06	0.000208	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	7.09e-06	0.000206	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	7e-06	0.000204	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	7e-06	0.000204	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.97e-06	0.000203	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	6.91e-06	0.000201	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PPARG—Alzheimer's disease	6.91e-06	0.000201	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	6.85e-06	0.0002	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.78e-06	0.000198	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—INS—Alzheimer's disease	6.77e-06	0.000197	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.76e-06	0.000197	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	6.7e-06	0.000195	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	6.57e-06	0.000191	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	6.52e-06	0.00019	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	6.48e-06	0.000189	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	6.43e-06	0.000187	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	6.38e-06	0.000186	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	6.38e-06	0.000186	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	6.34e-06	0.000185	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	6.33e-06	0.000185	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	6.31e-06	0.000184	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	6.27e-06	0.000183	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	6.24e-06	0.000182	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	6.13e-06	0.000179	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—NOS3—Alzheimer's disease	5.94e-06	0.000173	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.83e-06	0.00017	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.8e-06	0.000169	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	5.78e-06	0.000168	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—LPL—Alzheimer's disease	5.77e-06	0.000168	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	5.75e-06	0.000167	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	5.69e-06	0.000166	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	5.56e-06	0.000162	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	5.43e-06	0.000158	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.3e-06	0.000155	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—LPL—Alzheimer's disease	5.26e-06	0.000153	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	5.19e-06	0.000151	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.87e-06	0.000142	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CALM1—Alzheimer's disease	4.85e-06	0.000141	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOE—Alzheimer's disease	4.83e-06	0.000141	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	4.83e-06	0.000141	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	4.8e-06	0.00014	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CAV1—Alzheimer's disease	4.79e-06	0.00014	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.78e-06	0.000139	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.77e-06	0.000139	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	4.73e-06	0.000138	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	4.72e-06	0.000138	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	4.69e-06	0.000137	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.46e-06	0.00013	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.45e-06	0.00013	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	4.44e-06	0.000129	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	4.42e-06	0.000129	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CALM1—Alzheimer's disease	4.42e-06	0.000129	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOE—Alzheimer's disease	4.41e-06	0.000128	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.4e-06	0.000128	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CAV1—Alzheimer's disease	4.37e-06	0.000127	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	4.34e-06	0.000126	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	4.33e-06	0.000126	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PPARG—Alzheimer's disease	4.21e-06	0.000123	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—INS—Alzheimer's disease	4.13e-06	0.00012	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	4.1e-06	0.000119	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	4.01e-06	0.000117	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.87e-06	0.000113	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.84e-06	0.000112	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—INS—Alzheimer's disease	3.8e-06	0.000111	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—INS—Alzheimer's disease	3.77e-06	0.00011	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	3.76e-06	0.00011	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	3.68e-06	0.000107	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.62e-06	0.000105	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.33e-06	9.7e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	3.31e-06	9.65e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.3e-06	9.62e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	3.09e-06	9.02e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.05e-06	8.87e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	3.03e-06	8.82e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	3.02e-06	8.8e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	2.83e-06	8.25e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	2.77e-06	8.07e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—AKT1—Alzheimer's disease	2.73e-06	7.95e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	2.61e-06	7.61e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	2.56e-06	7.45e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.66e-06	4.85e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.53e-06	4.46e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.52e-06	4.42e-05	CbGpPWpGaD
